Skip to content

Bristol Myers Squibb股价Morningstar

HomeGravelle7003Bristol Myers Squibb股价Morningstar

Bristol-Myers Squibb Company: Helsetjenester: 4,47: Morningstar Rating for aksjer gis på grunnlag av en analytikers estimat av en aksjes virkelige verdi. Det er en beregning/mening og ikke et faktum. Morningstar gir stjerne-ratinger på grunnlag av en analytikers estimat av en aksjes virkelige verdi, som baseres på fire komponenter: (1 Der Pharmakonzern Bristol-Myers Squibb hat über positive Daten aus dem ersten Teil der Studie CheckMate 227 berichtet, in denen Opdivo plus Yervoy mit einer Chemotherapie bei nicht-kleinzelligem Erstlinien-Lungenkrebs (NSCLC) verglichen wurde. The Board of Directors of Bristol Myers Squibb (NYSE:BMY) today declared a quarterly dividend of forty-five cents ($0.45) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on August 3, 2020, to stockholders of record at the close of business on July 6, 2020. 路透1月3日 - 百时美施贵宝(必治妥施贵宝,Bristol-Myers Squibb)()周四表示,将以约740亿美元收购新基(Celgene)CELG.O,这是史上规模最大的制药业并购案,将全球最大的两家癌症药物生产企业合二为一。百时美施贵宝和新基各自都面临挑战,一些华尔街分析师质疑此次合并能否解决问题。

Bristol-Myers Squibb annonce que la FDA américaine a approuvé son Zeposia pour le traitement d'adultes atteints de formes récurrentes de scléroses en plaques, ayant démontré une réduction

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy (Your California Privacy Rights Find real-time CELGRT - Bristol-Myers Squibb Co stock quotes, company profile, news and forecasts from CNN Business. View BristolMyers Squibb Company BMY investment & stock information. Get the latest BristolMyers Squibb Company BMY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Objetivo de inversión: Candriam Equities L Oncology Impact C EUR Cap: This sub-fund invests primarily in equities, and/or securities equivalent to equities, of companies throughout the world which are active in the health sector and which concentrate specifically on the research and development of cancer treatments. Back to Morningstar Indexes Morningstar US Target Dividend TR USD Name Ticker Weight Date LyondellBasell Industries NV DLY 2.77033 04/30/2020 Microchip Technology Inc Bristol-Myers Squibb Company BMY 1.98505 04/30/2020 Paychex Inc PAYX 1.98403 04/30/2020 Relative valuation technique determine the value of Bristol-Myers Squibb Co. by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock's value, such as earnings, book value, and sales. Bristol-Myers Squibb Photograph by George Frey/Bloomberg Two days after the long-awaited acquisition of the biotech firm Celgene by the big pharma giant Bristol-Myers Squibb , all is quiet.

百时美施贵宝Bristol-Myers Squibb(NYSE:BMY)周四表示,公司与Biogen Inc(NASDAQ:BIIB)和罗氏控股Roche Holding(PINX:RHHBY)签署授权协议,公司将获得合计4.70亿美元的预付款以及最高6.15亿美元的潜在里程碑付款。


GlobeNewswire MapKure, BeiGene and SpringWorks Announce Initiation of Phase 1 Clinical Trial of BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory

Top Research Reports for Bristol-Myers, BHP & CVS - March ... Today's Research Daily features new research reports on 16 major stocks, including Bristol-Myers Squibb (BMY), BHP Group (BHP) and CVS Health (CVS). BRISTOL-MYERS SQUIBB COMPANY : Target Price Consensus … BRISTOL-MYERS SQUIBB COMPANY analysts consensus, targets, ratings and recommendations | Nyse: BMY | Nyse Bristol Myers Squibb : Announces Dividend | MarketScreener

Bristol-Myers Squibb has been increasing its dividend for 10 years. Dividend Coverage. The dividend payout ratio of Bristol-Myers Squibb is 38.38 %. This payout ratio is at a healthy, sustainable level, below 75%. Dividend Sustainability. Based on earnings estimates, Bristol-Myers Squibb will have a dividend payout ratio of 24.49 % next year.

Bristol-Myers expects full-year earnings in the range of $3.80 to $3.90 per share. Bristol-Myers shares have decreased 20 percent since the beginning of the year, while the Standard & Poor's 500 Find the latest dividend history for Bristol-Myers Squibb Company Common Stock (BMY) at